# OnCo record paper-geometry-mono-1-lancet-oncol-2024-update (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-geometry-mono-1-lancet-oncol-2024-update/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-geometry-mono-1-lancet-oncol-2024-update" ;
  schema:name "Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial"@en ;
  schema:description "Later report from the GEOMETRY mono-1 trial registered as NCT02414139, in The Lancet Oncology (2024); its title describes an updated or longer-term analysis."@en ;
  schema:url <https://onco.cc/key-papers/paper-geometry-mono-1-lancet-oncol-2024-update/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(24)00441-8>, <https://pubmed.ncbi.nlm.nih.gov/39362249/>, <https://europepmc.org/article/MED/39362249>, <https://clinicaltrials.gov/study/NCT02414139> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(24)00441-8> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Wolf J, Hochmair M, Han JY, et al." ;
  onco:trials <https://onco.cc/trials/geometry-mono-1/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .